PMID: 9188764Jan 1, 1997Paper

Ischemic preconditioning reduces Op6 generation and prevents respiratory impairment in the mitochondria of post-ischemic reperfused heart of rat

Life Sciences
J W ParkM S Kim

Abstract

The present study was performed to test whether the ischemic preconditioning could reduce mitochondrial O2.- production and prevent mitochondrial respiratory impairment upon reperfusion of ischemic hearts. The isolated perfused rat hearts were subjected to 30 min of global ischemia and 20 min of reperfusion. Ischemic preconditioning was performed, involving three 5-min periods of ischemia, each followed by a 5-min reperfusion just before a sustained ischemia. Ischemic preconditioning improved the post-ischemic cardiac function and reduced LDH release and malondialdehyde production upon reperfusion. 02.- generation of mitochondria isolated from the preconditioned hearts was significantly lower than that of mitochondria from the non-preconditioned hearts, and none of the activities of mitochondrial antioxidant enzymes (SOD, catalase, glutathione peroxidase) was altered as a consequence of the ischemic preconditioning alone. The impairment of mitochondrial state 3 respiration induced by ischemia and reperfusion was prevented by ischemic preconditioning. Amytal, a reversible respiratory chain blocker suppressing 02.- production in mitochondria, prevented the ischemia/reperfusion injury. The cardioprotective effect of Amytal could n...Continue Reading

References

Jul 1, 1979·Physiological Reviews·B ChanceA Boveris
Oct 1, 1978·European Journal of Biochemistry·H NohlD Hegner
Aug 1, 1977·Journal of Molecular and Cellular Cardiology·D J Hearse
Feb 1, 1991·Mechanisms of Ageing and Development·R S Sohal, B H Sohal
Apr 1, 1990·Circulation Research·R J SchottW Schaper
Jan 17, 1985·The New England Journal of Medicine·J M McCord
Jan 1, 1988·Free Radical Biology & Medicine·A Bindoli
Dec 30, 1986·Biochemical and Biophysical Research Communications·C M GrumM Shlafer
Sep 1, 1985·Journal of Molecular and Cellular Cardiology·H M PiperP G Spieckermann
Aug 1, 1966·Analytical Biochemistry·Z A PlacerB C Johnson
May 1, 1984·Journal of Molecular and Cellular Cardiology·G K Asimakis, V R Conti
Jun 1, 1983·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·L Hillered, L Ernster
Jun 1, 1980·Journal of Molecular and Cellular Cardiology·W Rouslin, R W Millard
Jun 17, 1994·Annals of the New York Academy of Sciences·G SteevesP K Singal
Feb 1, 1993·Cardiovascular Research·D M YellonM S Marber
Sep 10, 2005·The Journal of Organic Chemistry·Trond V HansenValery V Fokin

❮ Previous
Next ❯

Citations

Jul 11, 2001·Journal of Molecular and Cellular Cardiology·E J LesnefskyC L Hoppel
Aug 28, 2001·Free Radical Biology & Medicine·H SchwalbS R Powell
Mar 18, 2004·Antioxidants & Redox Signaling·Harjot K SainiNaranjan S Dhalla
Jun 29, 2010·Antioxidants & Redox Signaling·Kerstin BoenglerRainer Schulz
Mar 6, 2004·Circulation Research·Brian O'Rourke
Jun 5, 2002·American Journal of Respiratory and Critical Care Medicine·Tatsuo FukuseHiromi Wada
Sep 22, 2007·Journal of Molecular and Cellular Cardiology·Kerstin BoenglerRainer Schulz
Apr 2, 2002·The Journal of Surgical Research·Juan A CrestanelloMary D Osbakken
Feb 14, 2002·The Journal of Surgical Research·Juan A CrestanelloGlenn J R Whitman
Sep 21, 2007·Journal of Molecular and Cellular Cardiology·Smadar YitzhakiAsher Shainberg
Jun 10, 2010·Biochemical and Biophysical Research Communications·Qun ChenEdward J Lesnefsky
Mar 21, 2006·Archives of Biochemistry and Biophysics·Kathleen C Lundberg, Luke I Szweda
Mar 17, 2000·Circulation Research·T Vanden HoekP T Schumacker
Oct 4, 2011·Journal of Cardiovascular Pharmacology·Qun ChenEdward J Lesnefsky
Sep 15, 2006·American Journal of Physiology. Cell Physiology·Qun ChenEdward J Lesnefsky
Sep 22, 2005·The Journal of Pharmacology and Experimental Therapeutics·Qun ChenEdward J Lesnefsky
Sep 23, 2006·The Journal of Pharmacology and Experimental Therapeutics·Qun ChenEdward J Lesnefsky
Aug 20, 2005·The Biochemical Journal·Giancarlo Solaini, David A Harris
Jan 25, 2000·American Journal of Physiology. Heart and Circulatory Physiology·R M FryerG J Gross
Oct 25, 2007·Biochemical Society Transactions·E N Churchill, D Mochly-Rosen
Nov 5, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Leo G KevinDavid F Stowe
Jan 15, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Cevher OzcanAndre Terzic
Apr 2, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Petras P DzejaAndre Terzic
Apr 21, 2009·Translational Research : the Journal of Laboratory and Clinical Medicine·Sarah StewartQun Chen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.